My ePortfolio Register   
 

Abstract | Full HTML Article | PDF ecancer 3 145 / https://doi.org/10.3332/ecancer.2009.145

Review

Cell-cell fusion as a potential target in cancer therapy

In the fight against cancer, new and more specific targets are needed. Here, we offer an example of a potential target that has not been widely studied, namely the syncytin protein. Syncytin is expressed mainly in the human placenta and is implicated in placental syncytiotrophoblast cell fusion. Not much is known about the role of syncytin in cancer, but the existing data call for more intense research. Its retroviral origin and particular tissue distribution make syncytin an interesting potential target in cancer therapy.

Loading Article Metrics ... Please wait

Related articles

Research: Evidence on the cost of breast cancer drugs is required for rational decision making

Abstract | Full Article | PDF Published: 16 Apr 2018 / https://doi.org/10.3332/ecancer.2018.825

Review: Adipose tissue stem cells in regenerative medicine

Abstract | Full Article | PDF | Spanish Published: 28 Mar 2018 / https://doi.org/10.3332/ecancer.2018.822

Research: Diagnostic validity of fine-needle capillary cytology in palpable tumours at the Oncology Institute of Peru

Abstract | Full Article | PDF | Spanish Published: 01 Feb 2018 / https://doi.org/10.3332/ecancer.2018.805

Research: Men seeking counselling in a Breast Cancer Risk Evaluation Clinic

Abstract | Full Article | PDF Published: 30 Jan 2018 / https://doi.org/10.3332/ecancer.2018.804

Review: A systematic review of the literature exploring the interplay between prostate cancer and type two diabetes mellitus

Abstract | Full Article | PDF Published: 25 Jan 2018 / https://doi.org/10.3332/ecancer.2018.802



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence